Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
Jerome Reichman
Edward Elgar Publishing eBooks, 2013
View PDFchevron_right
The WTO’s Compulsory Licencing of Patented Pharmaceuticals: Implementation Challenges
Milorad Stamenovic
Međunarodna politika 75(1190):39-55, 2024
View PDFchevron_right
Trade Rules and Intellectual Property Protection for Pharmaceuticals
Valbona Muzaka
View PDFchevron_right
Patents and Public Health in the WTO, FTAs and Beyond: Tension and Conflict in International Law
Tania Voon, Andrew D Mitchell
View PDFchevron_right
World policy battles on pharmaceutical patent protection : micro-history of a forum shift and its legal implications
Pablo Zapatero
2013
View PDFchevron_right
Developing Countries and Intellectual Property Enforcement Measures: Improving Access to Medicines through WTO Dispute Settlement
Melissa Blue Sky
View PDFchevron_right
Patents for Drugs and the Right to Development in International Law
Olasupo Owoeye
Law and Development Review, 2015
View PDFchevron_right
Does the international patent regime constitute an illegitimate obstacle to Global Health and if so are there any preferable alternatives?
Ben Poser
View PDFchevron_right
Intellectual Property Rights In Bilateral Investment Treaties and Access to Medicines: the Case of Latin America
Rosa Castro
The Journal of World Intellectual Property, 2006
View PDFchevron_right
Questioning the Frequency and Wisdom of Compulsory Licensing for Pharmaceutical Patents
Scott Kieff
SSRN Electronic Journal, 2010
View PDFchevron_right
Patents, trade and medicines: past, present and future
Amy Kapczynski
Review of International Political Economy, 2019
View PDFchevron_right
Towards an Intellectual Property Bargaining Theory: The Post-WTO Era
Bruno Salama
SSRN Electronic Journal, 2010
View PDFchevron_right
Trade-Related Aspects of Intellectual Property Rights
Richard Mshomba
Cambridge University Press eBooks, 2009
View PDFchevron_right
Reframing the issue: The WTO coalition on intellectual property and public health, 2001
Susan Sell
… , ed. Negotiating Trade: Developing Countries in …, 2006
View PDFchevron_right
Analysis of TRIPS Agreement and the justification of international IP rights protection in the WTO's multilateral trading system, with particular reference to pharmaceutical patents
Jae Sundaram
Information & Communications Technology Law, 2015
View PDFchevron_right
TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines
HILDE STEVENS
Pharmaceutics, 2021
View PDFchevron_right
Globalizing ion Standard of Patent Protection in WTO Law and Policy Options for the LDCs
Monirul Azam
View PDFchevron_right
Global Issues and Business in International Relations: Intellectual Property Rights and Access to Medicines
Yoshiko KOJO
International Relations of the Asia-Pacific, 2018
View PDFchevron_right
India's trade-related aspects of Intellectual Property Rights compliant pharmaceutical patent laws: what lessons for India and other developing countries?
Jae Sundaram
Information & Communications Technology Law, 2014
View PDFchevron_right
The renaissance of compulsory licenses (in the pharma sector)
Blanka Szupera
Essays of Faculty of Law University of Pécs, Yearbook of [year]
View PDFchevron_right
Prizes for Pharmaceuticals? Mitigating the Social Ineffectiveness of the Current Pharmaceutical Patent Arrangement
Valbona Muzaka
View PDFchevron_right
Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis
Randall Kuhn
2012
View PDFchevron_right
The TAFTA, TTIP, and Treatment Access: What Does the Agreement Mean for Intellectual Property Rights Over Essential Medicines?
Faisal Chaudhry
The Transatlantic Colossus,: lobal Contributions To Broaden The Debate On The EU-US Free Trade Agreement, eds. David Cardoso, et al.., 2014
View PDFchevron_right
Effects Of The Trade Related Aspects of Intellectual Property (TRIPS) On Access to Pharmaceuticals in Developing Countries
Birute Aleknaite
View PDFchevron_right
PRODUCT PATENTS AND ACCESS TO INNOVATIVE MEDICINES IN A POST-TRIPS ERA
Jayashree WAtal
SSRN, 2019
View PDFchevron_right
Patent Bargains in NICs: the Case of Brazil
Bruno Salama
ALACDE, 2008
View PDFchevron_right
Impact of Trade Related Aspects of Intellectual Property Rights on Indian Pharmaceutical Industry
Mohammad Miyan
View PDFchevron_right
A proposal for measuring the degree of public health- sensitivity of patent legislation in the context of the WTO TRIPS Agreement
Gabriela Chaves
2007
View PDFchevron_right
Public Law Challenges to the Regulation of Pharmaceutical Patents in the US Bilateral Free Trade Agreement
Hitoshi Nasu
2010
View PDFchevron_right
The Inadequate Global Policy Response to Trade-Related Intellectual Property Rights: Impact on Access to Medicines in Low- and Middle-Income Countries
Lisa Forman
Maryland Journal of International Law, 2016
View PDFchevron_right
Drugs in a brave new world of trips+ schemes : the case for legal ceilings on extra patent protection
Pablo Zapatero
2013
View PDFchevron_right
How do intellectual property law and international trade agreements affect access to antiretroviral therapy?
Arachu Castro
PLoS medicine, 2006
View PDFchevron_right
Global intellectual property protection of “innovative” pharmaceuticals
Thomas Faunce
View PDFchevron_right
The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines under the Amended TRIPS Provisions†
Jerome Reichman
Journal of International Economic Law - J INT ECON LAW, 2007
View PDFchevron_right
Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Jorge Antonio
Bulletin of the World …, 2004
View PDFchevron_right